Landmark preclinical study cured lung metastases in 50 percent of breast cancers by making nanoparticles inside the tumor
A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lung metastases in mice. This landmark study appears today in Nature Biotechnology.
The majority of cancer deaths are due to metastases to the lung and liver, yet there is no cure. Existing cancer drugs provide limited benefit due to their inability to overcome biological barriers in the body and reach the cancer cells in sufficient concentrations. Houston Methodist nanotechnology and cancer researchers have solved this problem by developing a drug that generates nanoparticles inside the lung metastases in mice.
In this study, 50 percent of the mice treated with the drug had no trace of metastatic disease after eight months. That’s equivalent to about 24 years of long-term survival following metastatic disease for humans.
Due to the body’s own defense mechanisms, most cancer drugs are absorbed into healthy tissue causing negative side effects, and only a fraction of the administered drug actually reaches the tumor, making it less effective, said Mauro Ferrari, Ph.D, president and CEO of the Houston Methodist Research Institute. This new treatment strategy enables sequential passage of the biological barriers to transport the killing agent into the heart of the cancer. The active drug is only released inside the nucleus of the metastatic disease cell, avoiding the multidrug resistance mechanism of the cancer cells. This strategy effectively kills the tumor and provides significant therapeutic benefit in all mice, including long-term survival in half of the animals.
This finding comes 20 years after Ferrari started his work in nanomedicine. Ferrari and Haifa Shen, M.D., Ph.D., are co-senior authors on the paper, which describes the action of the injectable nanoparticle generator (iNPG), and how a complex method of transporting a nano-version of a standard chemotherapy drug led to never before seen results in mice models with triple negative breast cancer that had metastasized to the lungs.
“This may sound like science fiction, like we’ve penetrated and destroyed the Death Star, but what we discovered is transformational. We invented a method that actually makes the nanoparticles inside the cancer and releases the drug particles at the site of the cellular nucleus. With this injectable nanoparticle generator, we were able to do what standard chemotherapy drugs, vaccines, radiation, and other nanoparticles have all failed to do,” said Ferrari.
Houston Methodist has developed good manufacturing practices (GMP) for this drug and plans to fast-track the research to obtain FDA-approval and begin safety and efficacy studies in humans in 2017.
“I would never want to overpromise to the thousands of cancer patients looking for a cure, but the data is astounding,” said Ferrari, senior associate dean and professor of medicine, Weill Cornell Medicine. “We’re talking about changing the landscape of curing metastatic disease, so it’s no longer a death sentence.”
The Latest on: Injectable nanoparticle generator
via Google News
The Latest on: Injectable nanoparticle generator
- Harnessing body heat to power electronic devices on November 16, 2018 at 6:09 am
Turning down the heat on thermal power To charge personal devices using thermoelectric materials, a generator harnesses the Seebeck ... tellurium nanowires, silicon nanoparticles or 2-D materials like ... […]
- Biomimetic enzyme cascade reaction system in microfluidic electrospray microcapsules on June 15, 2018 at 12:14 pm
To realize the encapsulation, we integrated a coaxial capillary microfluidic chip with three-bore capillary injection channels using the electrospray ... Under an open electric field from a voltage ge... […]
- Cancer battling nanoparticle method devised on March 19, 2016 at 2:02 pm
To achieve this, an injectable nanoparticle generator is required and developing this has taken 20 years. This complex process allows a cancer drug (called doxorubicin) to hit the required spot with b... […]
- The Newest Cancer Treatment: Nanoballs Filled With Poison to Stop Tumors From Dividing on March 16, 2016 at 1:19 pm
The paper describes an injectable nanoparticle generator that can bypass biological barriers in mice that prevent cancer meds from reaching their target. Loaded with the chemotherapy agent doxorubicin ... […]
- Injectable nanoparticle generator could radically transform metastatic cancer treatment on March 13, 2016 at 5:00 pm
A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lu... […]
- This 15-year-old won $25,000 for devising a genius way to harvest energy from the ocean on October 14, 2015 at 12:07 pm
Herbst told Business Insider she was inspired by her 9-year-old pen pal ... won fourth place for her project to stop allergies at their source by inhalation or injection of nanoparticles that block pa... […]
- This 15-year-old won $25,000 for devising a genius way to harvest energy from the ocean on October 14, 2015 at 11:14 am
The 15-year-old from Boca Raton, Florida ... won fourth place for her project to stop allergies at their source by inhalation or injection of nanoparticles that block particles that trigger allergies. ... […]
- UCF now ranks as a powerhouse for patents on December 23, 2013 at 11:23 am
The titles of some were apparently spit out by a random word generator: Cerium Oxide Nanoparticle Regenerative Free Radical Sensor, anyone? And what kid doesn't want a High-Temperature, Wirebondless, ... […]
- Good-Bye Chemotheraphy? Retired Broadcaster Designs Possible Breakthrough Cancer Cure on August 29, 2007 at 5:00 pm
"It's a kick-ass cancer cell generator," cancer survivor and inventor John ... The method works by a patient first receiving an injection of gold nanoparticles, which would attach themselves to the ca... […]
- Functional Brain Imaging Using a Long Intravenous Half-Life Gadolinium-Based Contrast Agent on June 11, 2005 at 5:00 pm
1–5 Mandeville et al 6 have shown that a long intravenous half-life contrast agent, monocrystalline iron oxide nanoparticles (MION ... With the advent of new, long intravenous half-life gadolinium-bas... […]
via Bing News